An Integrated Metabolomic Study of Osteoporosis: Discovery and Quantification of Hyocholic Acids as Candidate Markers

Bibliographic Details
Title: An Integrated Metabolomic Study of Osteoporosis: Discovery and Quantification of Hyocholic Acids as Candidate Markers
Authors: Dawei Deng, Chen Pan, Zeming Wu, Yujiao Sun, Chang Liu, Hong Xiang, Peiyuan Yin, Dong Shang
Source: Frontiers in Pharmacology, Vol 12 (2021)
Publisher Information: Frontiers Media S.A., 2021.
Publication Year: 2021
Collection: LCC:Therapeutics. Pharmacology
Subject Terms: osteoporosis, lipids, bile acids, ageing, metabolomics, Therapeutics. Pharmacology, RM1-950
More Details: Osteoporosis is becoming a highly prevalent disease in a large proportion of the global aged population. Serum metabolite markers may be important for the treatment and early prevention of osteoporosis. Serum samples from 32 osteoporosis and 32 controls were analyzed by untargeted metabolomics and lipidomic approaches performed on an ultra-high performance liquid chromatography and high-resolution mass spectrometry (UHPLC-HRMS) system. To find systemic disturbance of osteoporosis, weighted gene correlation network analysis (WGCNA) and statistical methods were employed for data-mining. Then, an in-depth targeted method was utilized to determine potential markers from the family of key metabolites. As a result, 1,241 metabolites were identified from untargeted methods and WGCNA indicated that lipids metabolism is deregulated and glycerol phospholipids, sphingolipids, fatty acids, and bile acids (BA) are majorly affected. As key metabolites of lipids metabolism, 66 bile acids were scanned and 49 compounds were quantified by a targeted method. Interestingly, hyocholic acids (HCA) were found to play essential roles during the occurrence of osteoporosis and may be potential markers. These metabolites may be new therapeutic or diagnosis targets for the screening or treatment of osteoporosis. Quantified measurement of potential markers also enables the establishment of diagnostic models for the following translational research in the clinic.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1663-9812
Relation: https://www.frontiersin.org/articles/10.3389/fphar.2021.725341/full; https://doaj.org/toc/1663-9812
DOI: 10.3389/fphar.2021.725341
Access URL: https://doaj.org/article/fb77a6562ea845f19381ad737121e6bb
Accession Number: edsdoj.fb77a6562ea845f19381ad737121e6bb
Database: Directory of Open Access Journals
More Details
ISSN:16639812
DOI:10.3389/fphar.2021.725341
Published in:Frontiers in Pharmacology
Language:English